The involvement of IL-12 and IL-27 in immunity to Mycobacterium tuberculosis

IL-12和IL-27参与结核分枝杆菌免疫

基本信息

项目摘要

Tuberculosis is a disease that rennains a nnajor thireat to global public health. The severity of the epidemic has been intensified by the frequency of coinfection with HIV in developing nations and the emergence of multidrug resistant strains. Novel approaches to stimulate a more protective immune response are of particular interest to combat the increase in drug resistant strains. Our long-term objective is to understand the involvement of interleukin (IL)-12 and IL-27 in human macrophage responses and the impact of these responses on the complete immune response during tuberculosis. The major hypothesis to be investigated in this proposal is that autocrine/paracrine response to IL-27 impedes macrophage effector functions that control growth of M. tuberculosis. Oui- preliminary results have indicated that when IL-27 is neutralized during infection of IL-12-treated macrophages, there is a significant reduction in mycobacterial recovery. Consistent with control of mycobacterial growth is elevated production of interferon (IFN)-D and TNF-D by infected macrophages treated with IL-12 and a soluble receptor to neutralize IL-27. The first aim utilizes molecular approaches to identify important cytokines and test the hypothesis that tumor necrosis factor and IFN-D are indispensable to this mechanism. The second specific aim investigates the consequences of IL- 12 treatment and neutralization of IL-27 on macrophage effector functions. The rationale involved is that IFN-D produced as a result of this treatment promotes a toxic intracellular environment that hinders mycobacterial growth. The work described in this aim investigates the involvement of nitric oxide in the macrophage response during infection and examines progression ofthe mycobacterial phagosome within the endosomal pathway. The third specific aim tests the hypothesis that novel mechanisms operate to control transcription of IL-27 EBI3 and p28 genes. Since IL-27 is involved in host responses to a number of chronic infections and disease states, including tuberculosis, it is important to understand the molecular mechanisms that regulate IL-27 gene expression. We have proposed basic research into host immune responses during infection that could have implications in design of therapeutic strategies and vaccines.
结核病是一种对全球公共卫生构成重大威胁的疾病。疫情严重程度 在发展中国家,艾滋病毒合并感染的频率和 多药耐药菌株刺激更具保护性的免疫反应的新方法是 特别关注对抗耐药菌株的增加。我们的长期目标是了解 白细胞介素(IL)-12和IL-27参与人类巨噬细胞反应,以及这些细胞因子对巨噬细胞的影响。 结核病期间的完全免疫反应。待研究的主要假设 在该建议中,对IL-27自分泌/旁分泌反应阻碍巨噬细胞效应子功能, 控制M.结核初步结果表明,当IL-27被中和时, 在IL-12处理的巨噬细胞的感染过程中,分枝杆菌的恢复显著减少。 与分枝杆菌生长的控制相一致的是,干扰素(IFN)-D和TNF-D的产生增加, 感染的巨噬细胞用IL-12和可溶性受体处理以中和IL-27。第一个目标是利用 分子方法来确定重要的细胞因子和测试的假设,肿瘤坏死因子和 IFN-D是这一机制不可或缺的。第二个具体目标是调查IL- 图12显示IL-27对巨噬细胞效应子功能的治疗和中和。所涉及的理由是, 由于这种治疗产生的IFN-D促进了毒性细胞内环境, 分枝杆菌生长。在这个目标中描述的工作调查了一氧化氮在 巨噬细胞的反应,并检查内的分枝杆菌吞噬体的进展 内体途径第三个具体目标检验了一个假设,即新机制的运作, 控制IL-27、EBI 3和p28基因的转录。由于IL-27参与宿主对多种肿瘤的应答, 慢性感染和疾病状态,包括结核病,重要的是要了解分子 调节IL-27基因表达的机制。我们建议对宿主免疫进行基础研究 感染期间的反应,可能对治疗策略和疫苗的设计产生影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Cory Michael Robinson其他文献

Cory Michael Robinson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Cory Michael Robinson', 18)}}的其他基金

Understanding IL-27 as a negative regulator of protective immunity during neonatal sepsis
了解 IL-27 作为新生儿败血症期间保护性免疫的负调节因子
  • 批准号:
    10624257
  • 财政年份:
    2021
  • 资助金额:
    $ 24.28万
  • 项目类别:
Understanding IL-27 as a negative regulator of protective immunity during neonatal sepsis
了解 IL-27 作为新生儿败血症期间保护性免疫的负调节因子
  • 批准号:
    10278311
  • 财政年份:
    2021
  • 资助金额:
    $ 24.28万
  • 项目类别:
Understanding IL-27 as a negative regulator of protective immunity during neonatal sepsis
了解 IL-27 作为新生儿败血症期间保护性免疫的负调节因子
  • 批准号:
    10414998
  • 财政年份:
    2021
  • 资助金额:
    $ 24.28万
  • 项目类别:
The regulation of early life interleukin-27 expression and metabolic impact
生命早期 IL-27 表达的调节和代谢影响
  • 批准号:
    10040906
  • 财政年份:
    2020
  • 资助金额:
    $ 24.28万
  • 项目类别:
The regulation of early life interleukin-27 expression and metabolic impact
生命早期 IL-27 表达的调节和代谢影响
  • 批准号:
    10171779
  • 财政年份:
    2020
  • 资助金额:
    $ 24.28万
  • 项目类别:
Cellular expression and regulation of interleukin-27 in the neonatal immune syste
新生儿免疫系统中白细胞介素27的细胞表达和调节
  • 批准号:
    8978385
  • 财政年份:
    2014
  • 资助金额:
    $ 24.28万
  • 项目类别:
Cellular expression and regulation of interleukin-27 in the neonatal immune syste
新生儿免疫系统中白细胞介素27的细胞表达和调节
  • 批准号:
    8890783
  • 财政年份:
    2014
  • 资助金额:
    $ 24.28万
  • 项目类别:
Cellular expression and regulation of interleukin-27 in the neonatal immune syste
新生儿免疫系统中白细胞介素27的细胞表达和调节
  • 批准号:
    8753444
  • 财政年份:
    2014
  • 资助金额:
    $ 24.28万
  • 项目类别:
The involvement of IL-12 and IL-27 in immunity to Mycobacterium tuberculosis
IL-12和IL-27参与结核分枝杆菌免疫
  • 批准号:
    8528691
  • 财政年份:
    2011
  • 资助金额:
    $ 24.28万
  • 项目类别:
The involvement of IL-12 and IL-27 in immunity to Mycobacterium tuberculosis
IL-12和IL-27参与结核分枝杆菌免疫
  • 批准号:
    8166093
  • 财政年份:
    2011
  • 资助金额:
    $ 24.28万
  • 项目类别:

相似国自然基金

Segmented Filamentous Bacteria激活宿主免疫系统抑制其拮抗菌 Enterobacteriaceae维持菌群平衡及其机制研究
  • 批准号:
    81971557
  • 批准年份:
    2019
  • 资助金额:
    65.0 万元
  • 项目类别:
    面上项目
电缆细菌(Cable bacteria)对水体沉积物有机污染的响应与调控机制
  • 批准号:
    51678163
  • 批准年份:
    2016
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目

相似海外基金

Cell Wall Formation in Rod Shaped Bacteria
杆状细菌细胞壁的形成
  • 批准号:
    BB/Y003187/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.28万
  • 项目类别:
    Research Grant
Did light dictate ancient diversification of phylogeny and cell structure in the domain bacteria?
光是否决定了细菌领域的古代系统发育和细胞结构的多样化?
  • 批准号:
    24H00582
  • 财政年份:
    2024
  • 资助金额:
    $ 24.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Conference: Symposium on the Immune System of Bacteria
会议:细菌免疫系统研讨会
  • 批准号:
    2349218
  • 财政年份:
    2024
  • 资助金额:
    $ 24.28万
  • 项目类别:
    Standard Grant
DNA replication dynamics in living bacteria
活细菌中的 DNA 复制动态
  • 批准号:
    23K25843
  • 财政年份:
    2024
  • 资助金额:
    $ 24.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
  • 批准号:
    EP/Y023528/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.28万
  • 项目类别:
    Research Grant
NPBactID - Differential binding of peptoid functionalized nanoparticles to bacteria for identifying specific strains
NPBactID - 类肽功能化纳米粒子与细菌的差异结合,用于识别特定菌株
  • 批准号:
    EP/Y029542/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.28万
  • 项目类别:
    Fellowship
Assembly of the matrix that supports bacteria living in biofilms
支持生活在生物膜中的细菌的基质的组装
  • 批准号:
    2468773
  • 财政年份:
    2024
  • 资助金额:
    $ 24.28万
  • 项目类别:
    Studentship
Manipulating two-component systems to activate cryptic antibiotic pathways in filamentous actinomycete bacteria
操纵双组分系统激活丝状放线菌中的神秘抗生素途径
  • 批准号:
    BB/Y005724/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.28万
  • 项目类别:
    Research Grant
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
  • 批准号:
    BB/Y007611/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.28万
  • 项目类别:
    Research Grant
CAREER: Interfacial behavior of motile bacteria at structured liquid crystal interfaces
职业:运动细菌在结构化液晶界面的界面行为
  • 批准号:
    2338880
  • 财政年份:
    2024
  • 资助金额:
    $ 24.28万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了